13
Read latest news

ACCELERATING CERTAINTY

Irish Medtech Company of the year 2023
find out more here >
44

DECIPHEX ACCELERATES CERTAINTY BY DIGITALLY NETWORKING THE WORLD'S PATHOLOGISTS AND LEVERAGING AI TO DRIVE EFFICIENT, HIGH-QUALITY REPORTING.

Pathology is an integral part of health service delivery, touching 95% of clinical care pathways.

Pathology is also a critical part of the drug development lifecycle, ensuring the safety and efficacy of new drugs in development.

There is a growing supply-demand dynamic in global pathology services.

A crunch point is developing due to increasing test volumes, increasing test complexity and declining pathologist numbers.

The use of Digital Pathology (workload balancing) and AI (process acceleration) will be a critical part of the solution.

Deciphex is at the forefront of this revolution, networking and AI enabling Pathologists from all corners of the globe to drive high-quality, efficient reporting, enhancing patient care and accelerating drug development.

DECIPHEX IS ACCELERATING PATHOLOGY SERVICE DELIVERY

Pathology is an integral part of health service delivery, touching 95% of clinical care pathways.

Pathology is also a critical part of the drug development lifecycle, ensuring the safety and efficacy of new drugs in development.

There is a growing supply-demand dynamic in global pathology services.

A crunch point is developing due to increasing test volumes, increasing test complexity and declining pathologist numbers.

The use of Digital Pathology (workload balancing) and AI (process acceleration) will be a critical part of the solution.

Deciphex is at the forefront of this revolution, networking and AI enabling Pathologists from all corners of the globe to drive high-quality, efficient reporting, enhancing patient care and accelerating drug development.

  • Pathology is an Integral Part of Health Service Delivery, it touches 95% of clinical care pathways.
  • There is a growing supply-demand dynamic in Global Pathology Services.
  • A crunch point is developing due to increasing test volumes, increasing test complexity and flat to declining pathologist numbers.
  • The use of digital pathology (workload balancing) and in artificial intelligence (process acceleration) will be a critical part of the solution for shortfalls in pathology services.
  • Deciphex plan to be at the forefront of this revolution, networking Pathologists from all corners of the globe to drive high-quality, efficient reporting, all while addressing the pathology productivity gap with digital pathology and AI.
Deciphex

What Makes us Different?

Workflow Solutions

Solutions not Toolkits:

Ergonomic workflows integrated with artificial intelligence to optimise pathologist productivity is key in delivery of Deciphex solutions.

Big Data

Triage not Diagnosis:

Deciphex places the emphasis on triaging out of high volume, low complexity samples, allowing pathologists the time needed to focus on difficult, more challenging content.

Workflow Solutions

Quality and Quantity:

Deciphex are focussed on integrating the highest quality proprietary annotated data sets for deep learning development and validation.

Big Data

Targeted Application Space:

Deciphex targets Human Gastrointestinal and Toxicologic Pathology use cases rather than attempting a one size fits all approach.

Deciphex

Remote Expert Subspecialty Pathology on Demand

Diagnexia is an online clinical pathology department that provides on-demand access to remote subspecialty pathologists for primary diagnostics and secondary consult services, supporting the acceleration of diagnostic turnaround times and delivery of the highest quality of patient care.

learn more
24
Deciphexback home

scanning service

Why invest in expensive capital for slide digitisation when you can rely on high quality contract digital pathology scanning services?

High Speed, Low Cost Digital Pathology Scanning at Deciphex.

find out more

The Team

Donal O’Shea
Founder & Chief Executive Officer

LinkedIn Profile

Donal is an experienced corporate officer in the technology and diagnostics sectors, having 20 years of business leadership experience from start-up through to large corporate enterprise. Donal has considerable M&A experience. He has founded three companies and has senior management experience in Slidepath, Genetix, Leica Microsystems and Leica Biosystems.  

Mairin Rafferty
Chief Operations Officer

LinkedIn Profile

Mairin (PhD, MBA) is an experienced COO with >15 years experience in startups and academia. She has considerable experience in operational management, research funding, research programme management and generating IP portfolios. As COO, she also manages all company day to day activities, including defining business strategy, financial, HR and IP.

35

John Nolan
Chief Commercial Officer

LinkedIn Profile

John has over 25 years Sales, Marketing and CEO experience in technology start-ups & publicly listed technology companies. He has in depth experience in commercialising research, identifying product/market fit & negotiating global licenses. John manages strategic relationships and go to market plans for Deciphex. John is passionate about helping clients simplify & transform the patient experience with AI & advanced service delivery models.

Jenny Fitzgerald PhD
Chief Experience Officer

LinkedIn Profile

Senior Project and Operations Manager with over 12 years experience in research team management including academic research and University lecturing. Produced numerous peer-reviewed research articles and books. Experienced & tactical project and resource manager, practiced in managing collaborative EU projects, and data management for clinical AI model development.

Runjan Chetty
Chief Medical Officer

LinkedIn Profile

Runjan is an experienced Anatomical Pathologist/Histopathologist specialising in GI and pancreatic pathology, who has held chairs of Pathology in South Africa & Glasgow. He was the Program Medical Director & Chief/Professor of Pathology at UHN & University of Toronto. He also was Head of Translational Pathology at the University of Oxford.

Pierre Moulin
Chief Scientific Officer

LinkedIn Profile

Pierre is a physician-scientist and pathologist with 15 years of experience in the pharmaceutical industry, specializing in safety studies and clinical trials. He's a pioneer in AI pathology models and is affiliated with the University Hospital in Lausanne and the University of Basel as a lecturer.

Andrea Rizzini
Chief Technology Officer

LinkedIn Profile

Andrea is an expert software consultant having 10+ years of experience covering a wide range of technical roles, using different technologies and paradigms.  Andrea has delivered cutting-edge cloud solutions in a range of fields such as GIS, Healthcare and Finance. Andrea has worked as senior software architect in companies such as Slidepath, Leica Biosystems and Mastercard.

Shane Ryan
General Manager Preclinical Pathology

LinkedIn Profile

Shane is an experienced, results-oriented manager with over 10+ years of experience in Digital Pathology. Shane has worked in regulated multinationals since 2008 and has held multiple management and leadership roles since 2014. Shane believes all problems can ultimately be solved through constant improvement.

Mirko Colleluori
Senior Director Research & Development Clinical Pathology

LinkedIn Profile

Mirko is an experienced software architect with 10+ years of engineering practice in fields like aerospace & defence, mobile gaming, wearables and AR solutions. Mirko's focus is on software product and engineering practice, quality and innovation. He has contributed significantly to Digital Pathology imaging solutions working in SlidePath and Leica Biosystems.

Ciara Mullin
Senior Director of Human Resources

LinkedIn Profile

Ciara is an experienced, diverse HR Manager with over 10 years experience in HR, Operations & customer service, primarily within multinational tech companies. CIPD accredited degree in HRM with particular experience in strategic recruitment, change management, training & development and employee relations. Ciara sees people as the greatest asset to any company.

Derek Small
Senior Director of Finance

LinkedIn Profile

Senior finance executive with over 15 years experience in the telecommunication, tech and cloud sectors, working from start-up level through to large multinationals. Experienced across a wide range of financial areas, and has managed financial operations in financial planning and management, transfer pricing, revenue recognition and financial controls.

Colin Doolan
VP Business Development, Research Pathology

LinkedIn Profile

Colin has almost 20 years of experience focused on the delivery of innovative digital pathology software & services to Academic, Research and Clinical markets. He has worked in both Start-Up and Large Corporate environments, fulfilling a broad remit of customer-facing roles in Business Development, Sales, Commercial Marketing and Strategic Product Management.

Brian Mulcahy
Director of QA, RA & IS Compliance

LinkedIn Profile

Highly experienced QA & RA professional with 15+ years in pharm and med tech industries. Brian has worked with a variety of companies including multinationals and start-ups. He has successfully guided a range of regulated medical products from development through to the market. Brian enjoys working with products that benefit patient wellbeing and drive innovation in the healthcare industry.

Anthony Johnson
UK Sales Manager

LinkedIn Profile

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

investors

ACT Venture CapitalIrrus InvestmentsIrrus InvestmentsIrrus InvestmentsNext Steps CapitalEnterprise IrelandInovaGI Partners of Illinois LLCEnterprise Ireland
40

Partners

latest news

Launch of IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls

September 16, 2024

Launch of IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls

Deciphex today announced the launch of VICT3R, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation

Read more
Diagnexia Receives Accreditation from the College of American Pathologists

July 11, 2024

Diagnexia Receives Accreditation from the College of American Pathologists

Diagnexia has successfully met the rigorous standards set by the College of American Pathologists (CAP).

Read more
Patholytix 4.0, Becomes First Platform to Support Future-proof Study Archival of Regulated Digital Safety Studies

May 30, 2024

Patholytix 4.0, Becomes First Platform to Support Future-proof Study Archival of Regulated Digital Safety Studies

Deciphex, a pioneering leader in GLP-compliant digital pathology solutions, announces today that it is the first DICOM-native platform to fully facilitate the archival and reconstruction of regulated digital studies. Previously unavailable, this advancement strengthens digital pathology's use in GLP drug safety assessment.

Read more
Diagnexia Accelerates Growth with Strategic Expansion within Exeter Science Park

April 30, 2024

Diagnexia Accelerates Growth with Strategic Expansion within Exeter Science Park

Diagnexia, the digital pathology diagnostics leader and a division of Deciphex, today unveiled its strategic relocation to a larger facility within Exeter Science Park.

Read more
Deciphex Enters into Collaboration Agreement with Novartis to Advance AI in Preclinical Studies

April 23, 2024

Deciphex Enters into Collaboration Agreement with Novartis to Advance AI in Preclinical Studies

Collaboration Agreement Seeks to engage AI to Transform Non-clinical Pathology Assessments in Drug Discovery and Development

Read more
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

April 11, 2024

Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

Powered by digital pathology and AI algorithms, Patholytix Foresight drives speed and quality in toxicologic pathology practices

Read more

Contact Details

Invent Buidling at DCU

Ireland

Deciphex
DCU Alpha Building, Innovation Campus,
11 Old Finglas Rd, Glasnevin, Co. Dublin
D11 KXN4

Call: +353 1 582 7193

Email: [email protected]

Twitter: @deciphex

USA

Deciphex Inc.
500 E Diehl RoadSuite 130,
Naperville,
IL 60563

Call: +1 708 573 0674

Email: [email protected]

USA Headquarters Building

UK

Diagnexia
Hedy Lamarr Building,
3 Babbage Way,
Exeter,
EX5 2FN

Call: +44 1 29730 2245

Email: [email protected]

UK

Oxford Accessioning Centre (UK)
Diagnexia UK Ltd,
Building B,
‍Langford Locks,
Kidlington,
OX5 1LH

Email Us

The details you submit will be used so that we can contact you in relation to your query either by email or your preferred method of contact. Read our privacy policy here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
Copyright Deciphex 2021
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.